Pharmaceutical

Oragenics acquires neurological assets from Odyssey Health

Oragenics has concluded the announced acquisition of assets focusing on neurological drug therapies and technologies from Odyssey Health.

Jan 3, 2024 - 18:00
Oragenics acquires neurological assets from Odyssey Health
Oragenics has concluded the announced acquisition of assets focusing on neurological drug therapies and technologies from Odyssey Health.
Read the original article

Tags:

Previous Article

UK MHRA introduces new procedure for medicine approvals

Next Article

EMA validates BMS’s repotrectinib application to treat cancer

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

EMA and FDA green-light MoonLake to advance IL-17 inhibitor

EMA and FDA green-light MoonLake to advance IL-17 inhib...

Feb 28, 2024

STAT+: Biogen board and C-suite are in step as they eye M&A opportunities, new CEO says

STAT+: Biogen board and C-suite are in step as they eye...

Jun 6, 2023

STAT+: Oscar Health names former Aetna executive as new CEO

STAT+: Oscar Health names former Aetna executive as new...

Mar 28, 2023